Alpha Genesis - About the company
Alpha Genesis is a series B company based in Yemassee (United States), founded in 2003. It operates as a Preclinical research services specializing in nonhuman primate models for therapy development. Alpha Genesis has raised $12.5M in funding. The company has 115 active competitors, including 11 funded and 20 that have exited. Its top competitors include companies like TransCure bioServices, GenOway and InVivo Biosystems.
Company Details
Preclinical research services specializing in nonhuman primate models for therapy development. They deliver comprehensive preclinical research services to advance biomedical discovery. They provide dependable resources tailored to sponsor needs, including primate models, quarantine services, colony management, breeding, and biological materials. Their GLP-capable laboratory and surgical platforms support complex pharmacology, toxicology, and translational studies. They offer services spanning exploratory research through IND-enabling studies, designed to de-risk candidate therapies and provide reproducible outcomes. They integrate advanced imaging, molecular analytics, and specialized model development to help sponsors generate data for clinical advancement. They uphold high standards of animal welfare, biosecurity, and regulatory compliance.
- Website
- www.alphagenesisinc.com/
- Email ID
- *****@alphagenesisinc.com
- Phone Number
- +1 **********
- Registered Address
- Yemassee, South Carolina
Key Metrics
Founded Year
2003
Location
Yemassee, United States
Stage
Series B
Total Funding
$12.5M in 1 round
Latest Funding Round
Ranked
5th among 115 active competitors
Employee Count
105 as on Jul 31, 2026
Similar Companies
Legal entities associated with Alpha Genesis
Alpha Genesis is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
ALPHA GENESIS, INC. CIN: 541800459 , United States, Active | - | 210 (As on Dec 31, 2024) | - | |
Alpha Genesis Inc CIN: 3453767 , United States, Active | - | 104 (As on Dec 31, 2016) | - |
Sign up to download Alpha Genesis' company profile
Alpha Genesis's funding and investors
Alpha Genesis has raised a total funding of $12.5M over 1 round.
Here is the list of recent funding rounds of Alpha Genesis:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jan 13, 2018 | 3570347 | Series B | 1695488 | 6428491 | 7541999 | 4514702 |
View details of Alpha Genesis's funding rounds and investors
Alpha Genesis' founders and board of directors
Founder? Claim ProfileAlpha Genesis' employee count trend
Alpha Genesis has 105 employees as of Jul 26. Here is Alpha Genesis's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Alpha Genesis's Competitors and alternates
Top competitors of Alpha Genesis include TransCure bioServices, GenOway and InVivo Biosystems. Here is the list of Top 10 competitors of Alpha Genesis, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | TransCure bioServices 2012, Archamps (France), Series B | Developer of humanized animal models for preclinical studies | $3.58M | 59/100 | |
2nd | Provider of transgenic rodent models and customized cell lines for preclinical development | $11.6M | 58/100 | ||
3rd | InVivo Biosystems 2019, Eugene (United States), Series A | Provider of animal models for in-vivo analytical services | $8.16M | 46/100 | |
4th | Magnitude Biosciences 2018, Durham (United Kingdom), Seed | Provider of early in vivo whole-organism high-throughput phenotypic screening and follow-up assays for drug discovery | $2.6M | 46/100 | |
5th | Alpha Genesis 2003, Yemassee (United States), Series B | Preclinical research services specializing in nonhuman primate models for therapy development | $12.5M | - | 45/100 |
6th | Animal models of neurological and psychiatric disorders for drug discovery | - | - | 40/100 | |
7th | Explora BioLabs 2004, San Diego (United States), Acquired | Provider of discovery pharmacology and vivarium services for biotechnology and pharmaceutical clients | - | 39/100 | |
8th | Fibrofind United Kingdom, Acquired | Provider of preclinical drug development research solutions for fibrotic diseases | - | - | 39/100 |
9th | ![]() MPP Group, LLC 2016, United States, Acquired | Provider of injectable drug development and analytical testing services | - | - | 37/100 |
10th | Noble Life Sciences 2010, Woodbine (United States), Seed | Preclinical contract research organization offering standard GLP and non-GLP services | $335K | 37/100 |
Looking for more details on Alpha Genesis's competitors? Click here to see the top ones
Alpha Genesis's Investments and acquisitions
Alpha Genesis has made no investments or acquisitions yet.
Reports related to Alpha Genesis
Here is the latest report on Alpha Genesis's sector:
News related to Alpha Genesis
Media has covered Alpha Genesis for a total of 7 events in the last 1 year, 4 of them have been about company updates.
•
•
•
•
•
Alpha Genesis Expands U.S. Primate Breeding Operations by 40% to Advance U.S. Scientific Self-RelianceAccess Newswire•Nov 11, 2025•Alpha Genesis
•
Alpha Genesis Expands GLP Capacity with Multi-Million-Dollar InvestmentNewswire•Oct 14, 2025•Alpha Genesis
•
•
Alpha Genesis Offers Immediate Placement for Displaced Research PrimatesNewswire•Apr 23, 2025•Alpha Genesis
•
•
Are you a Founder ?
FAQs about Alpha Genesis
Explore our recently published companies
- Alpenhof Murnau - 1967 founded, Unfunded company
- Alfa Romeo - Mexico based, Unfunded company
- Alma Lasers Medica - Spain based, 2009 founded, Unfunded company
- Alex Juel - Denver based, Unfunded company
- Alpha Media - Delhi based, 2012 founded, Unfunded company
- Alpha Horizons - Saudi Arabia based, 2005 founded, Unfunded company
